Thermo Fisher Scientific (TMO)
EBITDA Growth
-0.77%
TTM · Period ending:
TMO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-0.77%period ending
Latest reported-0.77%period ending
TMO TTM EBITDA YoY % (45.12% → -0.77%)
Year-over-year change
High-resolution chart · PNG
TMO ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 19.9435% | |
| 1.6606% | |
| -3.0293% | |
| -4.9929% | |
| -44.621% | |
| -42.4814% | |
| -41.355% | |
| -46.0854% | |
| -30.3282% | |
| -23.5206% | |
| -9.371% | |
| 6.5745% | |
| 31.7464% | |
| 61.583% | |
| 64.9709% | |
| 78.0942% | |
| 61.2177% | |
| 38.7677% | |
| 27.0144% | |
| 14.9555% | |
| 19.4359% | |
| 27.2152% | |
| 34.8556% | |
| 37.4444% | |
| 37.8493% | |
| 30.5785% | |
| 38.0435% | |
| 30.6241% | |
| 39.0203% | |
| 53.0156% | |
| 43.3022% | |
| 101.757% | |
| 101.3605% | |
| 134.1686% | |
| 166.0221% | |
| 86.1035% | |
| 41.6867% | |
| -4.3573% | |
| -16.2037% | |
| -15.2425% | |
| 14.011% | |
| 57.732% | |
| -75.0721% | |
| -85.6242% | |
| 198.645% | |
| -64.7273% | |
| 226.3653% | |
| 1,476.9634% | |
| -170.019% | |
| 127.9006% | |
| 415.534% | |
| 6,266.6667% | |
| -21.3433% | |
| -16.0093% | |
| -62.2711% | |
| -97.5806% | |
| 29.3436% | |
| 45.1178% |